Skip to main content
Humedix Co., Ltd. logo

Humedix Co., Ltd. — Investor Relations & Filings

Ticker · 200670 ISIN · KR7200670008 KO Manufacturing
Open in API
Filings indexed 317 across all filing types
Latest filing 2021-03-04 Proxy Solicitation & In…
Country KR South Korea
Listing KO 200670

About Humedix Co., Ltd.

https://humedix.com/eng/home.php?go=Ame…

Humedix Co., Ltd. is a healthcare company that develops and manufactures biological and pharmaceutical products focused on human health and beauty. The company specializes in hyaluronic acid-based applications, producing medical devices such as dermal fillers and arthritis treatments. Its portfolio also includes prescription medicines, active pharmaceutical ingredients (APIs), and functional cosmetics. Additionally, Humedix offers Contract Manufacturing Organization (CMO) services within the healthcare sector.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often associated with the DART system) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains information about the meeting date, agenda items, and proxy voting procedures. While it includes financial data, that data is provided as part of the proxy solicitation materials for the AGM, not as a standalone annual report or financial statement. Therefore, it is classified as Proxy Solicitation & Information Statement.
2021-03-04 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Humedix, detailing the date, location, and agenda items such as financial statement approval, director appointments, and business purpose changes. This document serves as the official notification and proxy-related information for an upcoming shareholder meeting, which falls under the Proxy Solicitation & Information Statement category.
2021-03-03 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Humedix) announcing a significant change in financial performance (revenue/profit structure) exceeding 15% or 30%. This is a standard 'Earnings Release' (ER) format used in the Korean market (DART system) to provide preliminary financial highlights before the final audited annual report is published. It includes key financial metrics, reasons for the change, and a disclaimer that it is based on internal data prior to external audit. FY 2020
2021-03-03 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 95% confidence The document is a 'Trust Contract Termination Result Report' (신탁계약해지결과보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the termination of a stock repurchase trust contract and the subsequent transfer of shares to the company's own account. In the context of financial filings, reports regarding the termination of share repurchase trusts and the resulting status of treasury shares are classified under 'Transaction in Own Shares' (POS), as they directly relate to the company's buyback activities and the management of its own shares.
2021-02-23 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) from Humedix, detailing quarterly financial highlights such as revenue, operating profit, and net income. It explicitly states these are provisional figures (잠정치) and provides a comparison against previous quarters and the same period in the prior year. This fits the definition of an Earnings Release (ER), which is the initial announcement of financial results. Q4 2020
2021-02-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Preliminary Earnings Release' (영업(잠정)실적) for Humedix, detailing quarterly financial performance (revenue, operating profit, net income) for the 4th quarter of 2020. It explicitly states these are preliminary figures (잠정치) and provides key financial highlights in a table format. This fits the definition of an Earnings Release (ER) as it is an initial announcement of periodical financial results. Q4 2020
2021-02-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.